Neuromodulation specialists play a crucial role in advancing the field of neurology by providing innovative, non-invasive, and minimally invasive treatments for a range of neurological conditions. These experts use electrical or pharmaceutical methods to modulate nerve activity in the brain, spinal cord, or peripheral nerves. Neuromodulation therapies are particularly valuable for patients suffering from chronic pain, movement disorders like Parkinson’s disease, epilepsy, and treatment-resistant depression. By carefully targeting specific neural circuits, neuromodulation specialists can help reduce symptoms and improve patients’ quality of life when traditional medications or surgeries are not effective. This patient-centered approach helps bridge the gap between neurological science and long-term symptom management.
In neurology, the integration of neuromodulation techniques is transforming how conditions are diagnosed and managed. Specialists in this area often work in multidisciplinary teams alongside neurologists, neurosurgeons, pain management experts, and rehabilitation therapists to deliver personalized care. Treatments such as spinal cord stimulation, deep brain stimulation (DBS), and vagus nerve stimulation (VNS) have shown significant clinical success. These therapies are tailored to each patient’s needs and monitored closely for effectiveness and safety. As research continues to evolve, neuromodulation specialists are at the forefront of exploring new applications of technology to treat complex neurological disorders, offering hope to patients who previously had limited options.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom